Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
६०८.७७६०८.७७६१२.९७६०८.७७
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
६४२.५८६४४.८७६४८.४८६४०.१८
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
८५१.१३८५५.६६८५८.७५८४५.५६
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
२१७.९८२१७.९८२१८.६५२१६.८८
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
९४८.९८९४८.५८९५७.८३९४१.९७
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२
GEKA:FRA
Genomma Lab Internacional SAB de CV
€ ०.७८
-०.६४%
(-०.००५०) 1D
अप्रिल ३०, २२:००:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GEKA...
Open
€ ०.७८
High
€ ०.७८
Low
€ ०.७८
Mkt. cap
१६.४८ अरब
Avg. vol.
२७.००
Volume
०.००
52-wk high
€ १.०९
52-wk low
€ ०.७६
No. of employees
२ हजार
News stories
From sources across the web
Profile
Genomma Lab Internacional or simply Genomma Lab is a Mexican company, founded in 1996, dedicated to the commercialization of OTC medications and dermocosmetic products. It is part of the Índice de Precios y Cotizaciones, the main stock index of the Mexican Stock Exchange. It is one of the leading pharmaceutical companies in the country. Genomma Lab Internacional, led by its owner Rodrigo Alonso Herrera Aspra, recorded net sales of 9,799.7 million Mexican pesos, equivalent to 756.0 million USD in 2012, achieving a 21.6% growth compared to 2011. Currently, Genomma Lab operates in 15 countries outside Mexico and has achieved success by replicating its business model. Wikipedia
About Genomma Lab Internacional SAB de CV
CEOJorge Luis Brake Valderrama
Employees१.६४ हजार
Founded१९९६
Headquarters-
Sector-
Previous reportsAll values in MXN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MXN
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
४.६८ अरब
४.४४ अरब
४.०२ अरब
४.१९ अरब
Cost of goods sold
१.७१ अरब
१.६१ अरब
१.५७ अरब
१.५३ अरब
Cost of revenue
१.७१ अरब
१.६१ अरब
१.५७ अरब
१.५३ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९७ अरब
१.९३ अरब
१.५० अरब
१.७० अरब
Operating expense
१.९४ अरब
१.८७ अरब
१.६५ अरब
१.७८ अरब
Total operating expenses
३.६५ अरब
३.४७ अरब
३.२२ अरब
३.३२ अरब
Operating income
१.०३ अरब
९६.७८ करोड
८०.०६ करोड
८७.४४ करोड
Other non operating income
-६.३० करोड
-७.५५ करोड
-६.२२ करोड
-७.२३ करोड
EBT including unusual items
५५.६८ करोड
६०.७६ करोड
५६.८१ करोड
६४.४१ करोड
EBT excluding unusual items
५५.६८ करोड
६०.७६ करोड
५६.८१ करोड
६४.४१ करोड
Income tax expense
२०.१९ करोड
१७.३५ करोड
२४.८४ करोड
१४.९५ करोड
Effective tax rate
३६.२५%
२८.५६%
४३.७३%
२३.२०%
Other operating expenses
-२.७० करोड
-६.२१ करोड
६.०६ करोड
-१४.४० लाख
Net income
३५.५० करोड
४३.४१ करोड
३१.९६ करोड
४९.४६ करोड
Net profit margin
७.५९%
९.७७%
७.९६%
११.८०%
Earnings per share
०.६७
०.६३
०.३२
०.४९
Interest and investment income
३.३२ करोड
२.९६ करोड
२.२८ करोड
-
Interest expense
-१९.४३ करोड
-१९.१६ करोड
-१९.०७ करोड
-१७.७८ करोड
Net interest expenses
-१६.१० करोड
-१६.२० करोड
-१६.७८ करोड
-१७.७८ करोड
Depreciation and amortization charges
-
-
८.५९ करोड
८.२० करोड
EBITDA
१.१२ अरब
१.०६ अरब
८९.५४ करोड
९६.५१ करोड
Gain or loss from assets sale
-१.३९ करोड
५७.०० हजार
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more